I. – Any change of establishment or use of premises intended to receive micro-organisms and toxins or products containing them, or any modification of the operations provided for in the authorisation, must first be the subject of a new application for authorisation addressed to the Director General of the Agence nationale de sécurité du médicament et des produits de santé under the conditions mentioned in Articles R. 5139-3 to R. 5139-7 .
Failure to submit a new application for authorisation will result in the immediate suspension of the initial authorisation until such time as the Director General of the Agency has ruled on its possible withdrawal, and without prejudice to any legal action that may be taken.
II – The following changes must be declared in advance to the Director General of the Agency:
1° Any new authorisation of a person by the holder of the authorisation under the conditions mentioned in 1° of Article R. 5139-3 ;
2° Any change likely to modify the risk analysis carried out by the applicant as part of the initial application;
3° Any change in the director of the establishment, which must be accompanied by the undertaking mentioned in 3° of article R. 5139-3 signed by the new director.
Failure by the authorisation holder to make a prior declaration in the aforementioned cases will result in immediate withdrawal of the authorisation, without prejudice to any legal action that may be taken.